Cite
HARVARD Citation
Lear, J. et al. (2018). Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. Journal of the European Academy of Dermatology and Venereology. pp. 372-381. [Online].